SurgePays Statistics
Share Statistics
SurgePays has 20.16M shares outstanding. The number of shares has increased by 38.77% in one year.
Shares Outstanding | 20.16M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 1.72% |
Owned by Institutions (%) | n/a |
Shares Floating | 13.95M |
Failed to Deliver (FTD) Shares | 51 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 392.32K, so 1.95% of the outstanding shares have been sold short.
Short Interest | 392.32K |
Short % of Shares Out | 1.95% |
Short % of Float | 2.86% |
Short Ratio (days to cover) | 3.13 |
Valuation Ratios
The PE ratio is 4.46 and the forward PE ratio is -17.78.
PE Ratio | 4.46 |
Forward PE | -17.78 |
PS Ratio | 0.67 |
Forward PS | 0.5 |
PB Ratio | 3.26 |
P/FCF Ratio | 9.19 |
PEG Ratio | n/a |
Enterprise Valuation
SurgePays Inc. has an Enterprise Value (EV) of 97.41M.
EV / Earnings | 4.72 |
EV / Sales | 0.71 |
EV / EBITDA | 4.85 |
EV / EBIT | 5.16 |
EV / FCF | 9.74 |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.18.
Current Ratio | 2.63 |
Quick Ratio | 1.91 |
Debt / Equity | 0.18 |
Total Debt / Capitalization | 15.26 |
Cash Flow / Debt | 2.02 |
Interest Coverage | 31.65 |
Financial Efficiency
Return on equity (ROE) is 0.73% and return on capital (ROIC) is 62.6%.
Return on Equity (ROE) | 0.73% |
Return on Assets (ROA) | 0.49% |
Return on Capital (ROIC) | 62.6% |
Revenue Per Employee | 6.23M |
Profits Per Employee | 937.18K |
Employee Count | 22 |
Asset Turnover | 3.27 |
Inventory Turnover | 11.22 |
Taxes
Income Tax | -2.27M |
Effective Tax Rate | -0.12 |
Stock Price Statistics
The stock price has increased by -66.54% in the last 52 weeks. The beta is 1.39, so SurgePays 's price volatility has been higher than the market average.
Beta | 1.39 |
52-Week Price Change | -66.54% |
50-Day Moving Average | 1.76 |
200-Day Moving Average | 2.94 |
Relative Strength Index (RSI) | 52.24 |
Average Volume (20 Days) | 507.51K |
Income Statement
In the last 12 months, SurgePays had revenue of $137.14M and earned $20.62M in profits. Earnings per share was $1.45.
Revenue | 137.14M |
Gross Profit | 35.64M |
Operating Income | 18.87M |
Net Income | 20.62M |
EBITDA | 20.08M |
EBIT | 18.87M |
Earnings Per Share (EPS) | 1.45 |
Balance Sheet
The company has $14.62M in cash and $5.44M in debt, giving a net cash position of $9.18M.
Cash & Cash Equivalents | 14.62M |
Total Debt | 5.44M |
Net Cash | 9.18M |
Retained Earnings | -15.19M |
Total Assets | 41.50M |
Working Capital | 28.48M |
Cash Flow
In the last 12 months, operating cash flow was $10.29M and capital expenditures -$281.30K, giving a free cash flow of $10.01M.
Operating Cash Flow | 10.29M |
Capital Expenditures | -281.30K |
Free Cash Flow | 10.01M |
FCF Per Share | 0.7 |
Margins
Gross margin is 25.99%, with operating and profit margins of 13.76% and 15.03%.
Gross Margin | 25.99% |
Operating Margin | 13.76% |
Pretax Margin | 13.4% |
Profit Margin | 15.03% |
EBITDA Margin | 14.64% |
EBIT Margin | 13.76% |
FCF Margin | 7.3% |
Dividends & Yields
SURG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 81.01% |
FCF Yield | 27.73% |
Analyst Forecast
The average price target for SURG is $9, which is 402.8% higher than the current price. The consensus rating is "Buy".
Price Target | $9 |
Price Target Difference | 402.8% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Stock Splits
The last stock split was on Nov 2, 2021. It was a backward split with a ratio of 1:50.
Last Split Date | Nov 2, 2021 |
Split Type | backward |
Split Ratio | 1:50 |
Scores
Altman Z-Score | 2.43 |
Piotroski F-Score | 3 |